RedHill Biopharma Gross Margin Growth & History (RDHL)

RedHill Biopharma's gross margin was 60.31% for fiscal 2024.

View full RedHill Biopharma company overview

RedHill Biopharma annual gross margin history

RedHill Biopharma annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20242024-12-3160.31%+13.28 pp
20232023-12-3147.03%+0.97 pp
20222022-12-3146.06%+3.67 pp
20212021-12-3142.39%−0.29 pp
20202020-12-3142.68%−21.41 pp
20192019-12-3164.09%−1.97 pp
20182018-12-3166.06%+19.12 pp
20172017-12-3146.94%−53.06 pp
20162016-12-31100.00%0.00 pp
20152015-12-31100.00%

RedHill Biopharma gross margin trends

Over the last five reported fiscal years, RedHill Biopharma's gross margin decreased from 64.09% to 60.31%, a change of −3.78 percentage points. The latest reported quarter, Q2 2022, shows 50.97%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review RedHill Biopharma filings at SEC.gov ↗